T-REX Acquisition Corp. Appoints Experienced CEO and New Director
Summary
T-REX Acquisition Corp. announced the appointment of Matthew Cohen as Chief Executive Officer and Katharyn Field to its Board of Directors, bringing significant public company leadership and financial expertise.
Key Events
-
New Chief Executive Officer Appointed
Matthew Cohen was appointed as Chief Executive Officer on January 2, 2026. He has over 38 years of experience in public company leadership, including roles as CEO/CFO of Stem Holdings, Inc., and expertise in public company financing and capital structuring.
-
New Independent Director Appointed
Katharyn Field was appointed to the Board of Directors on January 2, 2026. She is currently the CEO of iSpecimen Inc., a NASDAQ-listed biotech company, and has extensive experience in business strategies and executive leadership, including prior public company directorships.
Analysis
T-REX Acquisition Corp. has strengthened its leadership team with the appointment of Matthew Cohen as Chief Executive Officer and Katharyn Field to its Board of Directors. Matthew Cohen brings extensive experience in public company leadership, financing, and capital structuring, which is crucial for a micro-cap acquisition company. Katharyn Field's background as a CEO of a NASDAQ-listed company and her experience in business strategies and executive leadership further enhance the board's capabilities. These appointments are a positive development, signaling a focus on experienced leadership and potentially improving strategic direction and governance.
At the time of this filing, TRXA was trading at $1.80 on OTC in the Crypto Assets sector, with a market capitalization of approximately $47.7M. The 52-week trading range was $0.05 to $4.94. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.